M&A, Earnings and News Round Up: Keryx Biopharmaceuticals, Pandora Media, Marvell Technology Group, Starbucks, Cell

  M&A, Earnings and News Round Up: Keryx Biopharmaceuticals, Pandora Media,
            Marvell Technology Group, Starbucks, Cell Therapeutics

PR Newswire

NEW YORK, November 6, 2013

NEW YORK, November 6, 2013 /PRNewswire/ --

Market Buzz Report, an online investment portal, Announced important news and
developments for on Keryx Biopharmaceuticals (NASDAQ:KERX), Pandora Media
Inc(NYSE:P), Marvell Technology Group Ltd.(NASDAQ:MRVL), Starbucks
Corporation(NASDAQ:SBUX), Cell Therapeutics Inc(NASDAQ:CTIC).

Keryx Biopharmaceuticals(NASDAQ:KERX) announced successful top-line results
from its Phase 2 study of Zerenex (ferric citrate coordination complex) in
non-dialysis dependent chronic kidney disease (NDD-CKD) patients with elevated
serum phosphorus and iron deficiency anemia. In this study, Zerenex met both
co-primary endpoints, described below, demonstrating highly statistically
significant changes in serum phosphorus and transferrin saturation (TSAT)
versus placebo over the 12-week treatment period.

Why Hedge Funds Have Turned Bullish On KERX After The Solid News? Get All The
Details Herehttp://marketbuzzreport.com/index.php?code=KERX

In addition, Zerenex met the key secondary endpoints of increasing ferritin
and hemoglobin, and decreasing fibroblast growth factor-23 (FGF-23) versus
placebo. The Company plans to meet with the Food and Drug Administration (FDA)
to discuss these data with the goal of defining a path forward towards
obtaining a labeled indication for the treatment of iron deficiency anemia in
NDD-CKD patients.

Pandora Media Inc(NYSE:P) announced new metrics that were reached in the month
of October 2013. Listener hours for Pandora during the month of October 2013
were 1.47 billion, an increase of 18% from 1.25 billion during the same period
last year. Share of total U.S. radio listening for Pandora in October 2013 was
8.06%, an increase from 6.61% at the same time last year. Active listeners
were 70.9 million at the end of October 2013, an increase of 20% from 59.2
million during the same time period last year.

How Should Investors Trade P After The Recent News? Get Free Trend Analysis

FBR Capital notes Market Perform-rated Pandora reported October metrics before
the open on Tuesday. The key point: Listener hours rose 18% year over year, on
par with the 18% rise in Sept. This strongly supports the argument that the
iTunes Radio launch did not measurably slow listener growth, contrary to
fears. Pandora's self-measured share of U.S. radio listening rose 151 bps year
over year to 8.06%, suggesting that non-Pandora U.S. radio listening fell
5.5%, a step up from a 1.9% decline in September. The only slight negative for
Pandora came from monthly active users, which dipped 2.5% month over month to
70.9 million.

Marvell Technology Group Ltd.(NASDAQ:MRVL)'s shares soared over 9% on Tuesday
on reports that KKR & Co. has acquired almost 5% of computer chipmaker
Marvell Technology Group Ltd. (MRVL), As per reports from Bloomberg.

Is MRVL Still Hedge Fund's Favorite Ahead Of Earnings? Don't Miss The Free
Analysis Herehttp://marketbuzzreport.com/index.php?code=MRVL

KKR sees the Hamilton, Bermuda-based company as undervalued and has discussed
its holding with the company's co-founders, Chief Executive Officer Sehat
Sutardja and his brother Pantas, said one person, who asked not to be
identified as the information is private. One scenario New York-based KKR is
considering is a leveraged buyout of Marvell, though no such deal is imminent,
the person said.

Argus raises their Starbucks Corporation(NASDAQ:SBUX) target to $90 from $84,
as their review of co's growth initiatives has given them more confidence in
co's multichannel strategy. In fiscal 4Q13, despite a challenging economy and
aggressive competition, co used new products, promotions such as "treat
receipts," and social media to attract customers. Firm thinks management's
guidance for 10% revenue growth (down from 10%-13% previously) in FY14 is
conservative, and expect new beverages and single-serve products to boost
same-store sales.

Is SBUX Still The Hedge Fund's Favorite? Don't Miss The Free Analysis Here

Cell Therapeutics Inc(NASDAQ:CTIC) develops and commercializes treatments for
cancer. The company is focussing on building a biopharmaceutical company
having a diversified portfolio of oncology drugs.

Is CTIC The Best Pick In The Sector? Don't Wait, Just Get The Free Result

A lot of western mobile games have done well in China. Clash of Clans is doing
well amongst the top grossing iOS charts. Besides this, other games such as
Fruit Ninja, Temple Run 2 as well as Plants vs Zombies 2 are also performing
great. But, a number of international firms are doing business.

USMarketBuzz.com is an investment community that Focuses on MicroCap
Securities. USMarketBuzz.com is an authorative authentic Google News Site and
Leading Provider of Investment Awareness and Featured Company Profiles. If
you would like more information regarding our news coverage solutions, please
visit http://www.USMarketBuzz.com/  for more details. Get an edge on the
market with our Premium News Alerts  that are FREE for a limited time at
http://www.USMarketBuzz.com/. Follow us on Facebook:
https://www.facebook.com/usmarket.buzz Sign up for our FREE SMS News alerts
delivered directly to your mobile phone by texting the word PREPROMO to 27126.
(SMS alerts are free, however data rates may apply, check your wireless plan
for details.)

DISCLAIMER: FNNewswire (FNNW) is a third party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels. FNNW is NOT affiliated in any manner
with MarketBuzz Reports, USMarketBuzz.com or any company mentioned herein.
The commentary, views and opinions expressed in this release by MarketBuzz
Reports and USMarketBuzz.com are solely those of the MarketBuzz Reports &
USMarketBuzz.com and are not shared by and do not reflect in any manner the
views or opinions of FNNW. The companies that are discussed herein may or may
not have approved the statements made in this release. FNNW is not liable for
any investment decisions by its readers or subscribers FNNW and its affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. FNNW
was not compensated by any public company mentioned herein to disseminate this
press release.


This release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such forward-looking
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. "Forward-looking statements"
describe future expectations, plans, results, or strategies and are generally
preceded by words such as "may", "future", "plan" or "planned", "will" or
"should", "expected," "anticipates", "draft", "eventually" or "projected". You
are cautioned that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results to
differ materially from those projected in the forward-looking statements,
including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors,
and other risks identified in a company's annual report on Form 10-K or 10-KSB
and other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on
such statements. The forward-looking statements in this release are made as of
the date hereof and FNNW undertakes no obligation to update such statements.

FNNW Contact Information:
Company: FN Newswire
Contact email: editor@fnnewswire.com
U.S. Phone: +1(954)345-0611

SOURCE FN Media Group, LLC
Press spacebar to pause and continue. Press esc to stop.